Despite the rapid development of medicine, even nowadays, acute lymphoblastic leukemia
(ALL) is still a problem for pediatric clinicians. Modern medicine has reached a limit of …

Simple Summary Non-Hodgkin lymphoma is one of the most frequently occurring
hematologic diseases in the world. Current drugs and therapies have improved outcomes …

Nanoparticle-based therapies have been proposed in oncology research using various
delivery methods to increase selectivity toward tumor tissues. Enhanced drug delivery …

The past five decades have seen significant progress in our understanding of human
hematopoiesis. This has in part been due to the unprecedented development of advanced …

Objective This study aimed to develop and validate an assessment tool for predicting and
mitigating the risk of frailty in patients diagnosed with hematologic malignancies. Methods A …

B-cell malignancies are a heterogeneous group of diseases, for whom treatment options
include chemotherapeutics and immunotherapy. Despite the recent development of new …

Abstract [eng] Introduction. Acute leukemia is the most common oncological disease in
children. Children with acute lymphoblastic leukemia may develop hyperleukocytosis (blood …

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous malignant disease of
hematopoietic tissue. It is characterized by accumulation of abnormal blast cells mainly in …

Хроническое воспаление связано с процессом развития многих заболеваний, включая
сахарный диабет, целиакию, хронический аутоиммунный тиреоидит, муковисцидоз …